Q1 EPS Estimate for Tenet Healthcare Boosted by Analyst

Key Points

• Zacks Research has increased its Q1 2026 EPS forecast for Tenet Healthcare from $3.48 to $3.60, while the consensus estimate for the full-year earnings stands at $12.24 per share.
• Tenet Healthcare reported a significant EPS of $4.02 for the last quarter, exceeding the consensus estimate of $2.84 by $1.18, alongside a revenue of $5.27 billion.
• Analysts have mixed views on Tenet Healthcare's stock, with price targets ranging from $154 to $200, and a general average rating of "Moderate Buy".

Tenet Healthcare Corporation (NYSE:THC - Free Report) - Equities research analysts at Zacks Research boosted their Q1 2026 earnings per share (EPS) estimates for Tenet Healthcare in a research note issued to investors on Tuesday, August 5th. Zacks Research analyst R. Department now anticipates that the company will earn $3.60 per share for the quarter, up from their previous forecast of $3.48. The consensus estimate for Tenet Healthcare's current full-year earnings is $12.24 per share.

A number of other equities analysts also recently issued reports on the company. Truist Financial raised their price objective on Tenet Healthcare from $190.00 to $205.00 and gave the stock a "buy" rating in a research report on Wednesday, July 16th. Wall Street Zen upgraded shares of Tenet Healthcare from a "hold" rating to a "strong-buy" rating in a report on Saturday, July 26th. Morgan Stanley upped their price objective on shares of Tenet Healthcare from $175.00 to $210.00 and gave the company an "overweight" rating in a research note on Monday, June 9th. Robert W. Baird dropped their target price on shares of Tenet Healthcare from $195.00 to $167.00 and set a "neutral" rating on the stock in a report on Friday, July 25th. Finally, Mizuho increased their price target on Tenet Healthcare from $184.00 to $194.00 and gave the stock an "outperform" rating in a report on Friday, July 11th. Four research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $191.56.

Tenet Healthcare Trading Up 1.4%

NYSE:THC traded up $2.28 during trading hours on Wednesday, hitting $165.70. 734,141 shares of the company were exchanged, compared to its average volume of 1,716,906. The company has a fifty day simple moving average of $167.22 and a 200 day simple moving average of $147.25. Tenet Healthcare has a one year low of $109.82 and a one year high of $185.25. The stock has a market capitalization of $14.64 billion, a price-to-earnings ratio of 10.61, a price-to-earnings-growth ratio of 0.70 and a beta of 1.52. The company has a current ratio of 1.71, a quick ratio of 1.63 and a debt-to-equity ratio of 2.39.

Tenet Healthcare (NYSE:THC - Get Free Report) last announced its quarterly earnings results on Tuesday, July 22nd. The company reported $4.02 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.84 by $1.18. The firm had revenue of $5.27 billion during the quarter, compared to analysts' expectations of $5.16 billion. Tenet Healthcare had a net margin of 7.17% and a return on equity of 24.69%. The company's revenue was up 3.2% on a year-over-year basis. During the same period in the prior year, the company posted $2.31 EPS.

Insider Buying and Selling

In other Tenet Healthcare news, Director James L. Bierman sold 13,836 shares of the firm's stock in a transaction on Friday, May 23rd. The shares were sold at an average price of $159.58, for a total value of $2,207,948.88. Following the transaction, the director directly owned 41,435 shares of the company's stock, valued at approximately $6,612,197.30. This trade represents a 25.03% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Paola M. Arbour sold 7,738 shares of the business's stock in a transaction dated Thursday, June 5th. The stock was sold at an average price of $173.00, for a total transaction of $1,338,674.00. Following the sale, the executive vice president directly owned 20,110 shares of the company's stock, valued at approximately $3,479,030. The trade was a 27.79% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 49,120 shares of company stock worth $8,103,656 over the last quarter. Corporate insiders own 0.81% of the company's stock.

Institutional Investors Weigh In On Tenet Healthcare

Institutional investors have recently bought and sold shares of the stock. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA bought a new stake in shares of Tenet Healthcare in the 1st quarter worth $26,000. Wayfinding Financial LLC purchased a new position in Tenet Healthcare during the first quarter worth about $28,000. SVB Wealth LLC bought a new stake in Tenet Healthcare in the 1st quarter worth about $30,000. Colonial Trust Co SC lifted its position in shares of Tenet Healthcare by 85.7% during the 4th quarter. Colonial Trust Co SC now owns 247 shares of the company's stock worth $31,000 after buying an additional 114 shares in the last quarter. Finally, N.E.W. Advisory Services LLC bought a new position in shares of Tenet Healthcare in the first quarter valued at approximately $31,000. Institutional investors own 95.44% of the company's stock.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.